Related Experiment Video
Updated: May 11, 2026

10:16
Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment
Published on: March 28, 2022
ASCL1 reprograms mouse Muller glia into neurogenic retinal progenitors
Julia Pollak1, Matthew S Wilken, Yumi Ueki
1Department of Biological Structure, University of Washington, Seattle, WA 98195, USA.
Summary
A single transcription factor, Achaete-scute homolog 1 (Ascl1), can restore the regenerative potential of mammalian Müller glia (MG). Overexpressing Ascl1 in mouse MG induced a neurogenic state, enabling them to form new retinal neurons.
Area of Science:
- Neuroscience
- Developmental Biology
- Ophthalmology
Background:
- Mammalian Müller glia (MG) exhibit limited retinal regeneration compared to non-mammalian vertebrates.
- This regenerative failure is linked to the inability of mammalian MG to upregulate the proneural gene Achaete-scute homolog 1 (Ascl1) following injury.
Purpose of the Study:
- To investigate if overexpressing Ascl1 can restore the neurogenic potential of mammalian MG.
- To determine if Ascl1 can reprogram mature MG into neural progenitor cells capable of neuronal differentiation.
Main Methods:
- Overexpression of ASCL1 in cultured mouse MG and intact retinal explants.
- Analysis of gene expression changes, including upregulation of progenitor genes and downregulation of glial genes.
- Chromatin remodeling assessment to evaluate changes in gene accessibility.
Main Results:
- ASCL1 overexpression reprogrammed MG, leading to the upregulation of retinal progenitor-specific genes.
- Infected MG downregulated glial markers and exhibited chromatin remodeling towards an active configuration at target genes.
- MG-derived progenitors differentiated into cells with neuronal morphologies, expressed neuronal markers, and showed physiological responses.
Conclusions:
- A single transcription factor, ASCL1, is sufficient to induce a neurogenic state in mature mammalian MG.
- This finding highlights the potential of Ascl1 as a therapeutic target for retinal regeneration in mammals.

